Analysen von Emily Field
| 18.10.21 | Novo Nordisk Overweight | Barclays Capital | |
| 24.09.21 | AstraZeneca Overweight | Barclays Capital | |
| 05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
| 19.07.21 | Novo Nordisk Overweight | Barclays Capital | |
| 21.04.21 | Roche overweight | Barclays Capital | |
| 24.03.21 | Roche overweight | Barclays Capital | |
| 22.03.21 | AstraZeneca overweight | Barclays Capital | |
| 22.03.21 | Roche overweight | Barclays Capital | |
|
Werbung
|
|||
| 08.03.21 | AstraZeneca kaufen | Barclays Capital | |
| 11.02.21 | AstraZeneca overweight | Barclays Capital | |
| 04.02.21 | Novo Nordisk overweight | Barclays Capital | |
| 22.01.21 | AstraZeneca overweight | Barclays Capital | |
| 22.01.21 | Roche overweight | Barclays Capital | |
| 23.11.20 | AstraZeneca overweight | Barclays Capital | |
| 01.10.20 | Bayer overweight | Barclays Capital | |
| 09.09.20 | AstraZeneca overweight | Barclays Capital | |
| 10.08.20 | Roche overweight | Barclays Capital | |
| 06.08.20 | Bayer overweight | Barclays Capital | |
| 04.08.20 | Bayer overweight | Barclays Capital | |